Leaderboard

En | De
Sie sind hier: Urologie-Nephrologie 06. Juni 2026
Suchen
medline.ch
Urologie-Nephrologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Entzündung-Infekt
Nephrolithiasis
Niereninsuffizienz
Sexualität
Tumoren/BPH
Anderes
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 23672  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 473428  
   
Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma.
Discov Oncol
Zhou Y, Hu Z, Xie L, Zhang S, Huang Q, Zhang N, Liu Y, Zhang W, Wang K.
PMID: 42250062 [PubMed - as supplied by publisher]


Microstructure imaging of prostate cancer by diffusion MRI.
MAGMA
Szczepankiewicz F, Panagiotaki E, Molendowska M, Sandeman K, Palombo M, Wu D.
PMID: 42250048 [PubMed - as supplied by publisher]


Performance of large language models in urological decision support: a guideline-based comparative evaluation in urolithiasis.
Urolithiasis
Tunçekin A, Akta.
PMID: 42249916 [PubMed - indexed for MEDLINE]


Correction to "A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End-Stage Kidney Disease on Hemodialysis".
J Clin Pharmacol

PMID: 42249668 [PubMed - in process]


Kidney outcomes in pure membranous versus proliferative lupus nephritis: A 14-year Latin American cohort study.
Lupus
Rodelo-Ceballos J, Restrepo-Escobar M, Ustariz J, Taborda A, González LA.
PMID: 42249630 [PubMed - as supplied by publisher]


Quantitative Susceptibility Mapping of Kidney Stones: An Ex Vivo MRI Phantom Study.
Magn Reson Med
Mücke LH, Laun FB, de Figueiredo Cardoso R, Flé G, Lorenz J, Fichte A, Uder M, Bayerl N, Hanspach J.
PMID: 42249582 [PubMed - as supplied by publisher]


APOSCREEN-1 - a prospective, single-arm clinical trial for the implementation of a pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-Holstein.
BMC Nephrol
Amelunxen E, Kokot A, Kolbrink B, Thomsen SY, Meßtorff ML, Laudes M, Lienhard KR, Bachmann LM, Sievers LK, Schmitt R, Schulte K, von Samson-Himmelstjerna FA.
PMID: 42249426 [PubMed - as supplied by publisher]


Bladder, bowel, and sexual dysfunction are overlooked in the management of neurological conditions: a qualitative interview study.
BMC Neurol
Webb K, Clunie G, Cossou G, Roy H, Smith M, Drake M.
PMID: 42249384 [PubMed - as supplied by publisher]


Access to renal function information to improve pharmaceutical care in direct oral anticoagulant users: a cluster randomized trial protocol.
BMC Prim Care
Badran I, Clarenne J, Mongaret C, Ohl-Hurtaud A, Barbe C, Slimano F.
PMID: 42249299 [PubMed - as supplied by publisher]


[Endoscopic enucleation for prostate volumes ≥ 200 ml: current evidence, technical challenges, and clinical implications].
Urologie
Herrmann J, Hartung FO, Lusuardi L, Netsch C, Herrmann TRW.
PMID: 42249149 [PubMed - as supplied by publisher]


Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learning.
NPJ Digit Med
Lee JH, Li CX, Jahanandish H, Bhattacharya I, Vesal S, Song Y, Zhang L, Sang S, Choi MH, Soerensen SJC, Zhou SR, Sommer ER, Seibert TM, Fan R, Ghanouni P, Sonn GA, Rusu M.
PMID: 42249085 [PubMed - as supplied by publisher]


Epigenetic modulation of prostate cancer disparities in men with African ancestry.
Nat Rev Urol
Craddock J, Hayes VM.
PMID: 42249067 [PubMed - as supplied by publisher]


Deep learning based on multiparametric MRI for differentiating benign from malignant PI-RADS 3 prostate lesions: a dual-center study.
Sci Rep
Zhang H, Zheng Y, Ao W, Ding J, Liu B, Huang H, Zhang G, Huang D.
PMID: 42249012 [PubMed - as supplied by publisher]


Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.
Gut
Wong F, Adebayo D, George J, Idilman R, Hayes PC, Alvares-da-Silva MR, Torre A, Mekonnen HD, Seto WK, Sarin SK, Cao Z, Rajoriya N, Nagral A, Fisseha H, Kulkarni AV, Zhu C, Debzi N, Farias AQ, Su M, Goel A, Marciano S, Livingstone R, Dhiman RK, Gao Y, Malé-Velázquez R, Demitars CO, Bera C, Jiang YF, Velarde-Ruiz Velasco JA, Tan HK, Zhao C, Huezo MSG, Asrani SK, Wang L, Lu M, Michalczuk MT, Barutcu S, Cordova-Gallardo J, Gofton C, Gounder M, Shaw J, Albhaisi S, Zheng X, Aravinthan A, Rajaram RB, Jothimani D, Thanapirom K, Benitez C, Dincer D, Saraya A, Xu B, Lin M, Wu X, Liu C, Reddy R, Bush B, Thacker LR, Topazian M, Xie Q, Silvey S, Kamath PS, Choudhury A, Bajaj JS, CLEARED Investigators.
PMID: 42248676 [PubMed - as supplied by publisher]


Clinical Outcomes in Patients With Hypertension and Renal Artery Stenosis Across Age Categories.
Curr Probl Cardiol
Seri A, Hussain B, Aggarwal V, Mamas MA, Lichaa H, Alraies MC, Paul TK.
PMID: 42248492 [PubMed - as supplied by publisher]


Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY).
Lancet
Neuen BL, Heerspink HJL, Perkovic V, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Jongs N, Smeijer JD, Brinker M, Ahlers C, Lage A, Horvat-Bröcker A, Schloemer P, Eissing T, Dayoub R, Lawatscheck R, Agarwal R, FIND-CKD, FIDELIO-DKD and FIGARO-DKD Investigators.
PMID: 42248158 [PubMed - as supplied by publisher]


Immune tolerance: Parallels between pregnancy and kidney transplantation.
Hum Immunol
Agrawal S.
PMID: 42248030 [PubMed - as supplied by publisher]


Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study.
Eur J Surg Oncol
Filzmayer M, Quarta L, Petix M, Orlandi F, Goyal JA, Briganti A, Carmignani L, Micali S, Shariat SF, Kosiba M, Humke C, Saad F, Chun FK, Karakiewicz PI.
PMID: 42247963 [PubMed - as supplied by publisher]


Artificial intelligence in prostate cancer imaging: A mini-review of current applications and future directions.
Urol Oncol
Ergül MA, Sabur V.
PMID: 42247882 [PubMed - as supplied by publisher]


Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer.
Urol Oncol
Yajima S, Yoshida S, Chen W, Fukushima H, Tanaka H, Sato H, Hirakawa A, Masuda H, Fujii Y.
PMID: 42247881 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 473428    Seite 1 von 23672  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1